HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

The Bain Capital-backed company's debut comes as expectations of a softer trade policy and lower interest rates boost ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

So far this year, just 16 funded U.S. startups in the biotech, drug discovery and medical device spaces have made their ...

The stock of medical imaging and diagnostics software company Heartflow jumped 50% in its market debut on Aug. 8; the latest ...

An array of health-related updates includes the resolution of the U.S. saline shortage by the FDA, predictions about a missed ...

This year's cohort of new issues are rallying on their first day of trading, which bodes well for IPOs to come.